Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Lupin Ltd. is an innovation led transnational pharmaceutical company, which engages in the manufacture of pharmaceutical products. It offers branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. The firm caters to the cardiovascular, diabetology, asthama, pediatrics, central nervous system, gastro-intestinal, anti-infectives, nonsteroidal anti-inflammatory drug therapy, anti-tuberculosis, and cephalosporins industry segments. It operates through the following geographical segments: India, USA, Japan, and Others. The company was founded by Desh Bandhu Gupta in 1968 and is headquartered in Mumbai, India.

Panacea Biotec is an Innovation driven Biotechnology company doing Research and Development, Manufacturing, Sales, Distribution and Marketing of Pharmaceuticals, Vaccines and Biosimilars. Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited with a commitment to make Innovative Products Affordable and Accessible to the masses. It got publically listed on Indian National Stock Exchanges in September 1995 as Panacea Biotec Ltd. Panacea Biotec is witnessing a period of expansion across every aspect of their business from innovative products to customers in market, from manufacturing to regulatory approvals and thereby laying the foundation for translation of their vision in becoming greatest, largest and most admired biotechnology company in the World by 2020. Ardent Research and Development efforts have always been a great strength of Panacea Biotec. The main research areas are New Chemical Entities (NCE), New Biological Entities (NBE) Novel Drug Delivery System (NDDS) based pharmaceutical formulations, Novel peptides & human monoclonal antibodies and Vaccine development. The company has developed four distinguished, ultra-modern, state-of-art R&D centres in different locations, having internal capabilities for constant research, with over 300 highly professional and skilled scientists engaged in various aspects of research.

Zhejiang Starry Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of active ingredient and intermediate X-CT non-ionic contrast agent and fluoroquinolones series. Its products include fluorine quinoline derivatives, carbapenem, iohexol, ioversol, iopamidol, iopromide, iodixanol, levofloxacin, levofloxacin hydrochloride, levofloxacin acid ester, levofloxacin acid, pazufloxacin, pazufloxacin mesylate, meropenem, faropenem sodium, iomeprol, and gadobenate dimeglumine. The company was founded on September 15, 1997 and is headquartered in Taizhou, China.

Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD.

Pharmasyntez JSC is a private company headquartered in Irkutsk, Russia, also operating in Russia, that develops and manufactures pharmaceutical products.

Lifecare Innovations is a medical biotechnology company that engages in research, manufacturing, and marketing of healthcare products.

M&D specializes in the power plant and industrial facility diagnostic equipment development services.

Beijing Everbright Longtai Technology Co., Ltd., established on 2013-04-11, Business scope includes technology promotion,technology development,Technical Services;Medical Research and Experimental Development;Application software service;software development;Computer System Services;data processing(Bank Card Center in Data Processing,PUEvalue in1.4Except for the above cloud computing data centers).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

National Institute of Pharmaceutical Education & Research (doing business as NIPER) is an Indian company located in Sahibzada Ajit Singh Nagar and ultimately controlled by the Government of India that provides research services in pharmaceutical sciences. It was founded in 1998.

Manufactures pharmaceuticals

Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA.

Shanghai Pulmonary Hospital, a subsidiary of Tongji University, is a Chinese company located in Shanghai that provides medical services.

Shanghai Shanzhun Biotechnology Co., Ltd., established on 2015-07-16, Business scope includes licensed projects:Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product production(No licensed chemical products);Sales of Class I Medical Devices;Instrument sales;electronics sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Beijing Shengyiyao Technology Development Co., Ltd., established on 2001-04-02, The business scope includes the sale of third-class medical devices;Production of Class III medical devices;technology development,consult,Serve,transfer;software development;selling computers,Software and Auxiliary Equipment,medical instrumentsIkind,medical instrumentsIIkind;Import and export;Technology Import and Export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production of Class III medical devices,Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Nanjing Fusheng Pharmaceutical Technology Co., Ltd., established on 1997-01-30, Business scope includes pharmaceuticals,Nutraceuticals,Cosmetic technology development,transfer,consult,Serve;Pharmaceutical Intermediates,cosmetic,Chemical reagents and products,Sales of Disinfectants.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)